Medicine Recommendations

For the treatment of adults with insufficiently controlled type 2 diabetes mellitus to improve glycaemic control as an adjunct to diet and exercise.

Constipation in children

Constipation

Opioid-induced constipation

Schizophrenia (not first line)

The colour classification was determined as part of the collaborative work between LCFT and medicines Management leads. Local pathways and patient safety were taken into consideration.

Hyperphosphataemia in patients on haemodialysis or peritoneal dialysis

Use in patients being treated with anti-TNF biologics for Rheumatoid Arthritis

Digital Ulceration

Erectile dysfunction

Adjunct to normal treatment for severe eczema and allergic skin conditions

Type 2 diabetes

Rheumatoid arthritis

Breathlessness

Pain due to interstitial cystitis

Treatment of moderate to severe dry eyes

Osteoarthritis

NICE CG177 - Osteoarthritis: Care and management in adults

Narcolepsy with cataplexy

Unlicensed as a mood stabiliser

The colour classification was determined as part of the collaborative work between LCFT and medicines Management leads. Local pathways and patient safety were taken into consideration.

Hyperkalaemia

NICE TA599 - Sodium Zirconium Cyclosilicate for treating Hyperkalaemia

Treatment of Storage Symptoms associated with Benign Prostatic Hyperplasia

*FOR FYLDE & WYRE CCG ONLY* - For use in men who were already taking tamsulosin with some response; however the response was not adequate.

*FOR MORECAMBE BAY CCG ONLY* - Not to be used as first line

Treating excessive daytime sleepiness caused by narcolepsy (NICE TA758)

NICE TA 758 - Solriamfetol for treating excessive daytime sleepiness caused by narcolepsy